Caption Management, LLC Kura Oncology, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	BUY	$5.55 - $6.92 $55,500 - $69,200	10,000 New	10,000 $57,000
Q4 2024 Feb 14, 2025	BUY	$8.51 - $19.21 $212,750 - $480,250	25,000 New	25,000 $217,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $120,100 - $194,500	-10,000 Reduced 33.33%	20,000 $274,000
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $321,300 - $549,900	-30,000 Reduced 50.0%	30,000 $550,000
Q1 2022 May 13, 2022	SELL	$11.78 - $16.98 $175,522 - $253,002	-14,900 Reduced 19.89%	60,000 $963,000
Q4 2021 Feb 11, 2022	BUY	$12.22 - $19.57 $548,678 - $878,693	44,900 Added 149.67%	74,900 $1.05 Million
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $115,650 - $162,900	7,500 Added 33.33%	30,000 $562,000
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $469,125 - $672,300	22,500 New	22,500 $469,000

199

80.1M

53.6K

42.8K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $698M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.